On December 31, 2021, America Great Health (the “Company”) entered into a Supplementary Agreement with Zhigong Lin to amend his prior employment agreement with the Company dated August 31, 2021. The Supplement Agreements provides, inter alia, that Lin will be appointed Chief Executive Officer of GOF Biotechnologies, Inc., a newly-incorporated majority-owned subsidiary of the Company